#ASCO26 attendees: Join me today at 1:30 pm at E450a as we discuss our results of the phase 1b study using Azer-cel, an allogeneic CD19 CAR-T in R/R NHL and CLL, not previously exposed to CAR-T.
@TeamImugene @UMNCancer @UMNews #lymsm
@TeamImugene @UMNCancer @UMNews #lymsm